Equities

Shield Therapeutics PLC

STX:LSE

Shield Therapeutics PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)1.94
  • Today's Change0.036 / 1.89%
  • Shares traded3.14m
  • 1 Year change-74.36%
  • Beta1.5998
Data delayed at least 20 minutes, as of May 14 2024 12:23 BST.
More ▼
DateOpenHighLowCloseVolume
Tuesday, May 14, 2024Tue, May 14, 20241.902.002.001.943,135,0483.14m
Monday, May 13, 2024Mon, May 13, 20241.531.971.551.9013,915,19713.92m
Friday, May 10, 2024Fri, May 10, 20241.481.551.401.534,566,4004.57m
Thursday, May 09, 2024Thu, May 09, 20241.551.541.451.48690,175690.18k
Wednesday, May 08, 2024Wed, May 08, 20241.581.651.501.55660,833660.83k
Tuesday, May 07, 2024Tue, May 07, 20241.551.621.501.582,252,8422.25m
Friday, May 03, 2024Fri, May 03, 20241.651.631.461.558,522,0728.52m
Thursday, May 02, 2024Thu, May 02, 20241.752.001.561.6515,643,32215.64m
Wednesday, May 01, 2024Wed, May 01, 20241.351.801.351.7519,413,98219.41m
Tuesday, April 30, 2024Tue, Apr 30, 20241.351.401.231.3513,350,02713.35m
Monday, April 29, 2024Mon, Apr 29, 20241.351.451.321.355,942,4865.94m
Friday, April 26, 2024Fri, Apr 26, 20241.231.401.201.358,370,8358.37m
Thursday, April 25, 2024Thu, Apr 25, 20241.331.311.061.238,963,3378.96m
Wednesday, April 24, 2024Wed, Apr 24, 20241.431.451.301.332,958,0472.96m
Tuesday, April 23, 2024Tue, Apr 23, 20241.431.431.401.43700,061700.06k
Monday, April 22, 2024Mon, Apr 22, 20241.481.501.401.43705,761705.76k
Friday, April 19, 2024Fri, Apr 19, 20241.481.501.421.481,069,5351.07m
Thursday, April 18, 2024Thu, Apr 18, 20241.481.491.451.48486,264486.26k
Wednesday, April 17, 2024Wed, Apr 17, 20241.531.551.451.484,058,6914.06m
Tuesday, April 16, 2024Tue, Apr 16, 20241.531.551.501.535,113,2855.11m
Monday, April 15, 2024Mon, Apr 15, 20241.531.551.501.532,317,7252.32m
Data delayed at least 20 minutes, as of May 14 2024 13:23 BST.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.